Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast

Abstract

Background. Solid dispersions are among the techniques successfully employed to enhance the dissolution of poorly water-soluble drugs. Microwave (MW)-assisted evaporative crystallization has been used to prepare solid dispersions of drugs and polymers.Objectives. The aim of the study was to investigate the solubility of apremilast (APM) in water by exploring the effect of MW-assisted solid dispersion technology. Material and methods.In the present study, solid dispersions of APM, a poorly water-soluble drug, were prepared. The solid dispersions were prepared using the conventional method (CM) and the MW-based solvent evaporation technique. Microwave energy was used to enhance the solubility and dissolution rate of APM. The physical mixture and solid dispersions were characterized using Fourier-transform infrared spectroscopy (FTIR), X-ray powder diffraction (XRPD), differential scanning calorimetry (DSC), and scanning electron microscopy (SEM). Apremilast tablets containing MW-assisted solid dispersions were prepared by the direct compression technique and compared with the marketed formulation (Aprezo tablets). Results.The results obtained confirmed the conversion of crystalline APM to an amorphous form. The XRPD pattern of the MW-assisted formulation at a 2:1 ratio suggests the amorphous structure of APM within the formulation. Based on solubility studies results, Syloid ® 244FP was selected as the best carrier. The dissolution study results suggested that the APM tablet prepared using MW-assisted solid dispersions at a 2:1 carrier/drug ratio improved the APM dissolution rate compared to the marketed formulation.Conclusions. Based on the results, it can be concluded that the MW-assisted solid dispersion technique may be an effective approach to enhancing the dissolution profile of other poorly water-soluble drugs. Cite asMadan JR, Pawar AR, Patil RB, Awasthi R, Dua K. Preparation, characterization and in vitro evaluation of tablets containing microwave-assisted solid dispersions of apremilast.

Formulation, optimization, and in vitro evaluation of nanostructured lipid carriers for topical delivery of Apremilast

“…The NLC dispersion (batch F5) was lyophilized (Labconco, Free Zone 2.5 plus, Kansas City, Missouri) and used for Fourier‐transform infrared (FTIR) examination. The FTIR spectrum of pure APM, PM of APM and Compritol 888ATO (1:1 ratio), and lyophilized NLCs (batch F5) were recorded over a range of 4000 to 400 cm −1 to distinguish atomic structures and components using FTIR spectrophotometer (IR Prestige‐21, Shimadzu Corp., Tokyo, Japan) by potassium bromide disc method 33 …”

Formulation and In Vitro Evaluation of Casein Nanoparticles as Carrier for Celecoxib

“…CLXB and SOD-CAS were passed through a sieve # 100 and the physical mixture (PM) was prepared by mixing pre-weighed amount of CLXB with SOD-CAS at a 1:1 ratio. 34 …”

“…Micrographs were taken using Supra 5 SEM at an accelerating voltage of 10 kV. [34][35][36] Preparation of physical mixture CLXB and SOD-CAS were passed through a sieve # 100 and the physical mixture (PM) was prepared by mixing pre-weighed amount of CLXB with SOD-CAS at a 1:1 ratio. 34…”

“…After freeze-drying of the nanoparticles and re-suspending dried powder in SIFSLS 1% of the original concentration, transparent solutions were formed, that resemble very much the original suspension. 34…”

Formulation, optimization and in vitro evaluation of nanostructured lipid carriers for topical delivery of apremilast

“…During the formulation process, the lipid particles are cooled to crystallize and form solid particles. The two lipids Compritol ® 888ATO and oleic acid being spatially different, when mixed together create imperfections in the crystal order of the lipids leading to increased distance between fatty acid chains in the matrix structure of Compritol ® 888ATO [28,29]. Therefore, the formed matrix contains various deformities proposing more space to incorporate APM.…”